Literature DB >> 33255651

The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease.

Maria Fragiadaki1, Fiona M Macleod1, Albert C M Ong1.   

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is characterized by the progressive growth of cysts but it is also accompanied by diffuse tissue scarring or fibrosis. A number of recent studies have been published in this area, yet the role of fibrosis in ADPKD remains controversial. Here, we will discuss the stages of fibrosis progression in ADPKD, and how these compare with other common kidney diseases. We will also provide a detailed overview of some key mechanistic pathways to fibrosis in the polycystic kidney. Specifically, the role of the 'chronic hypoxia hypothesis', persistent inflammation, Transforming Growth Factor beta (TGFβ), Janus Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) and microRNAs will be examined. Evidence for and against a pathogenic role of extracellular matrix during ADPKD disease progression will be provided.

Entities:  

Keywords:  ADPKD; EMT; JAK/STAT; PKD1; PKD2; TGFβ; extracellular matrix (ECM); fibrosis; hypoxia; microRNAs

Mesh:

Substances:

Year:  2020        PMID: 33255651      PMCID: PMC7728143          DOI: 10.3390/ijms21238936

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  104 in total

1.  Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease.

Authors:  T Nakamura; C Ushiyama; S Suzuki; I Ebihara; N Shimada; H Koide
Journal:  Am J Nephrol       Date:  2000 Jan-Feb       Impact factor: 3.754

2.  PKD1 interacts with PKD2 through a probable coiled-coil domain.

Authors:  F Qian; F J Germino; Y Cai; X Zhang; S Somlo; G G Germino
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cells.

Authors:  Jessica Venugopal; Jeffrey McDermott; Gladis Sanchez; Madhulika Sharma; Leandro Barbosa; Gail A Reif; Darren P Wallace; Gustavo Blanco
Journal:  Exp Cell Res       Date:  2017-04-03       Impact factor: 3.905

Review 5.  Hypoxia-inducible factor 1 (HIF-1) pathway.

Authors:  Gregg L Semenza
Journal:  Sci STKE       Date:  2007-10-09

6.  Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.

Authors:  Edwin M Spithoven; Anneke Kramer; Esther Meijer; Bjarne Orskov; Christoph Wanner; Jose M Abad; Nuria Aresté; Ramón Alonso de la Torre; Fergus Caskey; Cécile Couchoud; Patrik Finne; James Heaf; Andries Hoitsma; Johan de Meester; Julio Pascual; Maurizio Postorino; Pietro Ravani; Oscar Zurriaga; Kitty J Jager; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

7.  Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.

Authors:  Foteini Patera; Alex Cudzich-Madry; Zhi Huang; Maria Fragiadaki
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

8.  MicroRNAs regulate renal tubule maturation through modulation of Pkd1.

Authors:  Vishal Patel; Sachin Hajarnis; Darren Williams; Ryan Hunter; Donovan Huynh; Peter Igarashi
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

9.  miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.

Authors:  Vishal Patel; Darren Williams; Sachin Hajarnis; Ryan Hunter; Marco Pontoglio; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-12       Impact factor: 11.205

10.  MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation.

Authors:  Qiong Li; Daoxiang Zhang; Yongbin Wang; Pan Sun; Xiaodan Hou; James Larner; Wujun Xiong; Jun Mi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  2 in total

1.  The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease.

Authors:  Abeda Jamadar; Sreenath M Suma; Sijo Mathew; Timothy A Fields; Darren P Wallace; James P Calvet; Reena Rao
Journal:  Cell Death Dis       Date:  2021-10-14       Impact factor: 8.469

2.  Rapidly Progressing to ESRD in an Individual with Coexisting ADPKD and Masked Klinefelter and Gitelman Syndromes.

Authors:  Ramón Peces; Carlos Peces; Rocío Mena; Emilio Cuesta; Fe Amalia García-Santiago; Marta Ossorio; Sara Afonso; Pablo Lapunzina; Julián Nevado
Journal:  Genes (Basel)       Date:  2022-02-23       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.